EP1456230 - FLAVIVIRUS NS1 SUBUNIT VACCINE [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 26.07.2019 Database last updated on 09.09.2024 | Most recent event Tooltip | 26.07.2019 | Withdrawal of application | published on 28.08.2019 [2019/35] | Applicant(s) | For all designated states Bavarian Nordic A/S Boegeskovvej 9 3490 Kvistgaard / DK | For all designated states Venture Technologies Sdn Bhd Unimas Research Park MY-94300 Kota Samarahan Sarawak / MY | [N/P] |
Former [2005/14] | For all designated states Bavarian Nordic A/S Boegeskovvej 9 3490 Kvistgaard / DK | ||
For all designated states Venture Technologies Sdn Bhd Unimas Research Park MY-94300 Kota Samarahan, Sarawak / MY | |||
Former [2004/38] | For all designated states Bavarian Nordic A/S Ved Amagerbanen 23 2300 Copenhagen S / DK | ||
For all designated states Venture Technologies Sdn Bhd Unimas Research Park MY-94300 Kota Samarahan, Sarawak / MY | Inventor(s) | 01 /
HOWLEY, Paul 60 Rose Avenue Glen Waverly, VIC 3140 / AU | 02 /
LEYRER, Sonja Fürstenriederstrasse 272 81377 München / DE | 03 /
CARDOSA, Mary Jane 96 Jalan Wan Abbul Rahman 4 MY-93300 Kuching, Sarawak / MY | 04 /
HENRY SUM, Magdeline Sia Lot 43 Lorong A5, Taman BDC MY-94300 Kuching / MY | [2004/38] | Representative(s) | Bendiksen, Henrik Bavarian Nordic GmbH Patent Department Fraunhoferstraße 13 82152 Martinsried / DE | [N/P] |
Former [2013/12] | Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE | ||
Former [2011/10] | Pielken, Petra, et al Bavarian Nordic GmbH Fraunhoferstrasse 13 82152 Martinsried / DE | ||
Former [2006/23] | Lenkkeri-Schütz, Ulla, et al Bavarian Nordic GmbH Fraunhoferstraße 13 82152 Martinsried / DE | ||
Former [2005/51] | Alt, Michael Bavarian Nordic GmbH, Fraunhoferstrasse 13 82152 Martinsried / DE | ||
Former [2004/38] | Alt, Michael, Dr. Bavarian Nordic GmbH, Fraunhoferstrasse 18b 82152 Martinsried / DE | Application number, filing date | 02804184.6 | 20.11.2002 | [2004/38] | WO2002EP12991 | Priority number, date | DK20010001804 | 04.12.2001 Original published format: DK 200101804 | [2004/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03048184 | Date: | 12.06.2003 | Language: | EN | [2003/24] | Type: | A2 Application without search report | No.: | EP1456230 | Date: | 15.09.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.06.2003 takes the place of the publication of the European patent application. | [2004/38] | Search report(s) | International search report - published on: | EP | 29.01.2004 | Classification | IPC: | A61K38/16 | [2012/18] | CPC: |
C07K14/005 (EP,US);
C07K14/18 (KR);
A61P31/12 (EP);
A61P31/14 (EP);
A61P37/04 (EP);
A61P37/06 (EP);
C12N15/11 (KR);
C12N15/63 (KR);
A61K2039/5256 (EP,US);
A61K2039/545 (EP,US);
C12N2710/24143 (EP,US);
C12N2770/24022 (EP,US);
|
Former IPC [2011/20] | C07K14/18, C12N15/863 | ||
Former IPC [2004/38] | C07K14/18 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/38] | Extension states | AL | 29.07.2004 | LT | 29.07.2004 | LV | 29.07.2004 | MK | 29.07.2004 | RO | 29.07.2004 | SI | 29.07.2004 | Title | German: | IMPFSTOFF AUS DER NS1-UNTEREINHEIT EINES FLAVIVIRUS | [2004/38] | English: | FLAVIVIRUS NS1 SUBUNIT VACCINE | [2004/38] | French: | VACCIN A SOUS-UNITE DE NS1 DE FLAVIVIRUS | [2004/38] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 05.07.2004 | National basic fee paid | 29.07.2004 | Designation fee(s) paid | 29.07.2004 | Examination fee paid | Examination procedure | deleted | Communication of intention to grant the patent | 27.06.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.07.2004 | Examination requested [2004/40] | 06.02.2009 | Despatch of a communication from the examining division (Time limit: M04) | 12.05.2009 | Reply to a communication from the examining division | 04.12.2009 | Despatch of a communication from the examining division (Time limit: M04) | 12.04.2010 | Reply to a communication from the examining division | 16.06.2010 | Despatch of a communication from the examining division (Time limit: M04) | 02.10.2010 | Reply to a communication from the examining division | 15.11.2010 | Despatch of a communication from the examining division (Time limit: M04) | 09.02.2011 | Reply to a communication from the examining division | 13.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 19.10.2011 | Reply to a communication from the examining division | 16.12.2011 | Despatch of a communication from the examining division (Time limit: M02) | 26.01.2012 | Reply to a communication from the examining division | 09.05.2012 | Communication of intention to grant the patent | 02.08.2012 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 09.10.2012 | Despatch of communication that the application is refused, reason: substantive examination {1} | 16.07.2019 | Application withdrawn by applicant [2019/35] | Appeal following examination | 27.11.2012 | Appeal received No. T0588/13 | 13.02.2013 | Statement of grounds filed | 16.07.2019 | Result of appeal procedure: the application was withdrawn | 21.11.2018 | Date of oral proceedings | 28.11.2018 | Minutes of oral proceedings despatched | Divisional application(s) | EP11000882.8 / EP2345665 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.02.2009 | Fees paid | Renewal fee | 30.11.2004 | Renewal fee patent year 03 | 30.11.2005 | Renewal fee patent year 04 | 30.11.2006 | Renewal fee patent year 05 | 30.11.2007 | Renewal fee patent year 06 | 01.12.2008 | Renewal fee patent year 07 | 30.11.2009 | Renewal fee patent year 08 | 30.11.2010 | Renewal fee patent year 09 | 23.11.2011 | Renewal fee patent year 10 | 13.11.2012 | Renewal fee patent year 11 | 18.11.2013 | Renewal fee patent year 12 | 10.11.2014 | Renewal fee patent year 13 | 10.11.2015 | Renewal fee patent year 14 | 10.11.2016 | Renewal fee patent year 15 | 10.11.2017 | Renewal fee patent year 16 | 14.11.2018 | Renewal fee patent year 17 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9001946 (US HEALTH [US]) [X] 23-35 * page 7, line 3 - page 10, line 30 *; | [Y]WO9813500 (BAVARIAN NORDIC RES INST AS [DK], et al) [Y] 1-35 * page 5, paragraph 2 - page 9, paragraph 4; examples 5,6; claim - *; | [X]US5824506 (CHAN LILY [SG], et al) [X] 1-4,6,12-15 * column 8, line 56 - column 15, line 48; claim - *; | [XY]WO0160847 (US HEALTH [US], et al) [X] 1-6,12-16 * page 5, line 1 - page 8, line 25 * * page 11, line 6 - page 25, line 6 * * example -; claim - * [Y] 1-35; | [PY]WO0242480 (BAVARIAN NORDIC RES INST AS [DK], et al) [PY] 1-35 * page 17, paragraph 3 - page 20, paragraph 2; claim - *; | [X] - SCHLESINGER JJ ET AL, "Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1", JOURNAL OF GENERAL VIROLOGY, (1987), vol. 68, no. 3, ISSN 0022-1317, pages 853 - 858, XP009015072 [X] 1-4,12-15 * abstract * * page 855, paragraph 2 - page 856, paragraph 3 * | [X] - CHAMBERS TJ ET AL, "Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (19971001), vol. 15, no. 14, ISSN 0264-410X, pages 1494 - 1502, XP004090331 [X] 1-4,12-15 * page 1499, column R, paragraph 1 - page 1500, column L, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0264-410X(97)00195-3 | [X] - BRAY M ET AL, "Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.", JOURNAL OF VIROLOGY, (1996), vol. 70, no. 6, ISSN 0022-538X, pages 4162 - 4166, XP002250234 [X] 1-3,12-14 * abstract * | [Y] - FALCONAR AK ET AL, "Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1", JOURNAL OF GENERAL VIROLOGY, READING, BERKS, GB, (199104), vol. 72, no. 4, ISSN 0022-1317, pages 961 - 965, XP000890192 [Y] 1-35 * abstract * * page 963, column R, paragraph 2 - page 965, column L, paragraph 1 * | Examination | - SHU P-Y ET AL, "Dengue NS1-specific antibody responses: Isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever", JOURNAL OF MEDICAL VIROLOGY, ALAN R. LISS, NEW YORK, NY LNKD- DOI:10.1002/1096-9071(200010)62:2<224::AID-JMV14>3.0.CO;2-C, vol. 62, no. 2, ISSN 0146-6615, (20001001), pages 224 - 232, (20000920), XP008102463 DOI: http://dx.doi.org/10.1002/1096-9071(200010)62:2<224::AID-JMV14>3.0.CO;2-C | - FALCONAR A ET AL, "Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein", ARCHIVES OF VIROLOGY, SPRINGER WIEN, AT LNKD- DOI:10.1007/BF01309478, (19940101), vol. 137, no. 3/04, ISSN 0304-8608, pages 315 - 326, XP002101238 DOI: http://dx.doi.org/10.1007/BF01309478 | - FALCONAR A K, "The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (1997), Database accession no. NLM9191856 | - ARCHIVES OF VIROLOGY 1997 LNKD- PUBMED:9191856, (1997), vol. 142, no. 5, ISSN 0304-8608, pages 897 - 916 | - FALCONAR A K, "The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis.", ARCHIVES OF VIROLOGY 1997 LNKD- PUBMED:9191856, (1997), vol. 142, no. 5, doi:doi:10.1007/s007050050127, ISSN 0304-8608, pages 897 - 916, XP002660273 DOI: http://dx.doi.org/10.1007/s007050050127 | - YOUNG P R ET AL, "An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients.", JOURNAL OF CLINICAL MICROBIOLOGY MAR 2000 LNKD- PUBMED:10698995, (200003), vol. 38, no. 3, ISSN 0095-1137, pages 1053 - 1057, XP002660274 | - ROTHMAN A L ET AL, "Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus.", JOURNAL OF VIROLOGY OCT 1996 LNKD- PUBMED:8794288, (199610), vol. 70, no. 10, ISSN 0022-538X, pages 6540 - 6546, XP002660275 | - Accession :AY603355 Esposito et al. Vaccinia virus strain Acambis 3000 Modified Virus Ankara (MVA), complete genome | - CHUNG KYUNG MIN ET AL, "Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.", JOURNAL OF VIROLOGY FEB 2006 LNKD- PUBMED:16415011, (200602), vol. 80, no. 3, doi:doi:10.1128/JVI.80.3.1340-1351.2006, ISSN 0022-538X, pages 1340 - 1351, XP002570237 DOI: http://dx.doi.org/10.1128/JVI.80.3.1340-1351.2006 | - LEE TAE HEE ET AL, "A cross-protective mAb recognizes a novel epitope within the flavivirus NS1 protein.", THE JOURNAL OF GENERAL VIROLOGY JAN 2012 LNKD- PUBMED:21918007, (201201), vol. 93, no. Pt 1, ISSN 1465-2099, pages 20 - 26 | - GAO GUANGPING ET AL, "Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.", HUMAN GENE THERAPY SEP 2008 LNKD- PUBMED:18788905, (200809), vol. 19, no. 9, ISSN 1557-7422, pages 927 - 936 | - SWISS PROT, Database accession no. P09866 | - SWISS PROT, Database accession no. P27915 | - GENBANK, Database accession no. AAD11533 | - GENBANK, Database accession no. AAB70694 |